SKYCLARYS
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for SKYCLARYS, covering 2023-02-28 to 2026-08-19. Get the full timeline:
Most recent: EMA Authorised: Skyclarys (omaveloxolone) — Biogen Netherlands B.V.